European Access Academy
A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
The
EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.
Fall Convention 2025
jointly hosted by the EAA and EURORDIS
'EU HTA - Procedural Insights & First Learnings'
at Université Paris Cité (Villemin Site)
on November 6/7, 2025
Registrations are now open.
Click
here for details and to register.
including a pre-Convention Meeting* on Nov 6th
on the challenges of small & medium-sized enterprises:
'EU HTA - Approaching Existing Gaps for SMEs'
jointly hosted by the EAA and EUCOPE.
*Participation by invitation only, contact info@euaac.org for inquiries.
Topical Collection at the Journal of Market Access and Health Policy on EU HTA:
The European Access Academy (EAA) and the Market Access Society (MAS) are editing a Topical Collection at JMAHP focusing on EU HTA, with Jörg Ruof and Mondher Toumi as guest editors. The goal of the Collection is to generate a comprehensive resource consolidating relevant information and diverse perspectives from various stakeholders and a range of focus topics regarding EU HTA.
Access the Collection HERE directly at the journal or find a list of all articles in this collection HERE.
EAA News & Media Posts - Archive
July 1st & 2nd, 2025: DG Santé Events on EU HTA in Brussels
The EAA would like to commend Maya Matthews and DG Santé for organizing exciting days on EU HTA in Brussels.
June 23, 2025: EAA Presentations at API-CCS event in Paris
Download the slides that were presented by the EAA Secretariat:
November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents
November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices
October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC
June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI
June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain
April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons
April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA
Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'
Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA
Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts
The EAA is an initiative hosted by Copenhagen University, Utrecht University, Vlerick Business School, Agència de Qualitat I Avaluació Sanitàries de Catalunya, Erasmus University, LUISS Business School and endorsed & funded by:
Springer Healthcare, Abbvie, AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, Pfizer, Roche, Sanofi , vfa, leem, EUCOPE and efpia.